ArticleFrontiers in oncology2022

Retinoic Acid Induces an IFN-Driven Inflammatory Tumour Microenvironment, Sensitizing to Immune Checkpoint Therapy.

Caitlin M Tilsed et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.